Haneen A. Al-Mazroua - Search Results

Year	Number of Results
2013	1
2019	2
2020	4
2021	2
2022	4

1

Dysregulation of Ki-67 Expression in T Cells of Children with Autism Spectrum Disorder.

Alhosaini K, Ansari MA, Nadeem A, Attia SM, Bakheet SA, Al-Ayadhi LY, Mahmood HM, Al-Mazroua HA, Ahmad SF. Alhosaini K, et al. Among authors: al mazroua ha. Children (Basel). 2021 Feb 6;8(2):116. doi: 10.3390/children8020116. Children (Basel). 2021. PMID: 33562037 Free PMC article.

2

5-Aminoisoquinolinone, a PARP-1 Inhibitor, Ameliorates Immune Abnormalities through Upregulation of Anti-Inflammatory and Downregulation of Inflammatory Parameters in T Cells of BTBR Mouse Model of Autism.

Alhosaini K, Ansari MA, Nadeem A, Bakheet SA, Attia SM, Alhazzani K, Albekairi TH, Al-Mazroua HA, Mahmood HM, Ahmad SF. Alhosaini K, et al. Among authors: al mazroua ha. Brain Sci. 2021 Feb 17;11(2):249. doi: 10.3390/brainsci11020249. Brain Sci. 2021. PMID: 33671196 Free PMC article.

3

3-Aminobenzamide alleviates elevated DNA damage and DNA methylation in a BTBR T⁺Itpr3^tf/J mouse model of autism by enhancing repair gene expression.

Attia SM, Ahmad SF, Nadeem A, Attia MSM, Ansari MA, As Sobeai HM, Al-Mazroua HA, Alasmari AF, Bakheet SA. Attia SM, et al. Among authors: al mazroua ha. Pharmacol Biochem Behav. 2020 Dec;199:173057. doi: 10.1016/j.pbb.2020.173057. Epub 2020 Oct 15. Pharmacol Biochem Behav. 2020. PMID: 33069747

4

DAPTA, a C-C chemokine receptor 5 (CCR5) antagonist attenuates immune aberrations by downregulating Th9/Th17 immune responses in BTBR T⁺ Itpr3tf/J mice.

Ahmad SF, Ansari MA, Nadeem A, Bakheet SA, Alotaibi MR, Alasmari AF, Alshammari MA, Al-Mazroua HA, Attia SM. Ahmad SF, et al. Among authors: al mazroua ha. Eur J Pharmacol. 2019 Mar 5;846:100-108. doi: 10.1016/j.ejphar.2019.01.016. Epub 2019 Jan 15. Eur J Pharmacol. 2019. PMID: 30658114

5

Involvement of CD45 cells in the development of autism spectrum disorder through dysregulation of granulocyte-macrophage colony-stimulating factor, key inflammatory cytokines, and transcription factors.

Ahmad SF, Ansari MA, Nadeem A, Bakheet SA, Al-Ayadhi LY, Alasmari AF, Alanazi MM, Al-Mazroua HA, Attia SM. Ahmad SF, et al. Among authors: al mazroua ha. Int Immunopharmacol. 2020 Jun;83:106466. doi: 10.1016/j.intimp.2020.106466. Epub 2020 Apr 4. Int Immunopharmacol. 2020. PMID: 32259699

6

CXC chemokine receptor 3 antagonist AMG487 shows potent anti-arthritic effects on collagen-induced arthritis by modifying B cell inflammatory profile.

Bakheet SA, Alrwashied BS, Ansari MA, Nadeem A, Attia SM, Alanazi MM, Aldossari AA, Assiri MA, Mahmood HM, Al-Mazroua HA, Ahmad SF. Bakheet SA, et al. Among authors: al mazroua ha. Immunol Lett. 2020 Sep;225:74-81. doi: 10.1016/j.imlet.2020.06.014. Epub 2020 Jun 23. Immunol Lett. 2020. PMID: 32590119

7

Upregulation of interleukin (IL)-31, a cytokine producing CXCR1 peripheral immune cells, contributes to the immune abnormalities of autism spectrum disorder.

Ahmad SF, Ansari MA, Nadeem A, Bakheet SA, Al-Ayadhi LY, Alsaad AMS, Assiri MA, Al-Mazroua HA, Attia SM. Ahmad SF, et al. Among authors: al mazroua ha. J Neuroimmunol. 2020 Dec 15;349:577430. doi: 10.1016/j.jneuroim.2020.577430. Epub 2020 Oct 24. J Neuroimmunol. 2020. PMID: 33130460

8

The histamine-4 receptor antagonist JNJ7777120 prevents immune abnormalities by inhibiting RORγt/T-bet transcription factor signaling pathways in BTBR T⁺ Itpr3^tf/J mice exposed to gamma rays.

Ahmad SF, Nadeem A, Ansari MA, Bakheet SA, Al-Mazroua HA, Khan MR, Alasmari AF, Alanazi WA, As Sobeai HM, Attia SM. Ahmad SF, et al. Among authors: al mazroua ha. Mol Immunol. 2019 Oct;114:561-570. doi: 10.1016/j.molimm.2019.09.007. Epub 2019 Sep 12. Mol Immunol. 2019. PMID: 31522074

9

Smo-Shh Agonist Purmorphamine Prevents Neurobehavioral and Neurochemical Defects in 8-OH-DPAT-Induced Experimental Model of Obsessive-Compulsive Disorder.

Gupta R, Mehan S, Sethi P, Prajapati A, Alshammari A, Alharbi M, Al-Mazroua HA, Narula AS. Gupta R, et al. Among authors: al mazroua ha. Brain Sci. 2022 Mar 2;12(3):342. doi: 10.3390/brainsci12030342. Brain Sci. 2022. PMID: 35326298 Free PMC article.

10

Cathepsin B inhibitor alleviates Th1, Th17, and Th22 transcription factor signaling dysregulation in experimental autoimmune encephalomyelitis.

Ansari MA, Nadeem A, Alshammari MA, Attia SM, Bakheet SA, Khan MR, Albekairi TH, Alasmari AF, Alhosaini K, Alqahtani F, Al-Mazroua HA, Ahmad SF. Ansari MA, et al. Among authors: al mazroua ha. Exp Neurol. 2022 May;351:113997. doi: 10.1016/j.expneurol.2022.113997. Epub 2022 Feb 2. Exp Neurol. 2022. PMID: 35122866

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results